Pimozide Tablets bulk supplier for pharma manufacturers

Pimozide Tablets 1 mg, 2 mg, 4 mg Suppliers & Bulk Manufacturers

Available Forms: Oral Tablets

Available Strengths: 1 mg, 2 mg, 4 mg

Reference Brands: Orap®(US & EU)

Pimozide is a typical antipsychotic that primarily works by blocking dopamine D2 receptors in the brain, reducing excessive dopaminergic activity. It is mainly used to treat chronic schizophrenia and delusional disorders. Additionally, pimozide is FDA-approved for managing Tourette’s syndrome to suppress severe motor and vocal tics when other treatments fail.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Pimozide Tablets? List it or send an offer →

Product Description: Pimozide tablets are FDA-approved in the United States for treating Tourette’s syndrome and are also indicated for chronic schizophrenia in select markets. In the EU, they are approved under strict guidelines for use in resistant schizophrenia and tic disorders. Both regions require compliance with GMP, pharmacovigilance, and detailed psychiatric safety data, especially concerning cardiac risks (QT prolongation). Registration demands a complete dossier including clinical data and labeling per FDA and EMA standards. To explore dossier-ready Pimozide tablets, APIs, and other available forms, visit Pharmatradz.com — your trusted B2B source for global pharmaceutical products.

Pimozide Tablets — third party manufacturing & bulk supply

Pimozide Tablets 1 mg, 2 mg, 4 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Pimozide Tablets is supplied as Oral Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Pimozide Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Pimozide Tablets →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Pimozide Tablets is listed as Oral Tablets in 1 mg, 2 mg, 4 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Pimozide Tablets is referenced against Orap®(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.